You are now leaving
this site
This link will take you to a third-party site that is not owned by US WorldMeds. Click “OK” if you would like to proceed or click “Cancel” to stay on this site.
Not an actual patient.
For certain adult and pediatric patients (12 years of age and older)† with advanced synovial sarcoma who have received prior chemotherapy, TECELRA is
Your T cells. Your treatment. Your journey.
TECELRA is a one-time therapy that uses your own T cells to destroy your cancer cells. Talk to your doctor about receiving HLA and MAGE-A4 biomarker testing to discover if TECELRA is right for you.†
Get started with testingHLA=human leukocyte antigen; MAGE=melanoma-associated antigen.
†
TECELRA is for people with certain HLA-A*02 types whose tumor expresses the MAGE-A4 antigen.
Discover what’s possible with TECELRA and see if it may
be the right treatment option for you or your loved one
See results
See how TECELRA may be able to shrink your synovial sarcoma tumors, potentially by your first scan.
Explore nowFind a Treatment Center
TECELRA is given by a dedicated team at TECELRA Authorized Treatment Centers (ATCs). Our locator tool can help you find one near you.
View map
INDICATION and IMPORTANT SAFETY INFORMATION
IMPORTANT SAFETY INFORMATION
and INDICATION
What is TECELRA?
TECELRA® is a medicine, called a genetically modified autologous T cell immunotherapy, that is used to treat synovial sarcoma. It is used when other kinds of treatment do not work. TECELRA is different from other cancer medicines because it is made from your own white blood cells that are made to recognize and attack your cancer cells. Your healthcare provider will perform tests to see if TECELRA is right for you.
IMPORTANT SAFETY INFORMATION
Important Warning: You will likely be in a hospital before and after getting TECELRA. TECELRA may cause side effects that can be severe or life-threatening. Call your healthcare provider or get emergency help right away if you get any of the following: fever (100.4°F/38°C or higher); chills/shivering; difficulty breathing; fast or irregular heartbeat; low blood pressure; fatigue; severe nausea, vomiting, or diarrhea; severe headache; or new skin rash. Tell all your healthcare providers that you were treated with TECELRA.
INDICATION and IMPORTANT SAFETY INFORMATION
IMPORTANT SAFETY
INFORMATION and INDICATION
What is TECELRA?
TECELRA® is a medicine, called a genetically modified autologous T cell immunotherapy, that is used to treat synovial sarcoma. It is used when other kinds of treatment do not work. TECELRA is different from other cancer medicines because it is made from your own white blood cells that are made to recognize and attack your cancer cells. Your healthcare provider will perform tests to see if TECELRA is right for you.
IMPORTANT SAFETY INFORMATION
Important Warning: You will likely be in a hospital before and after getting TECELRA. TECELRA may cause side effects that can be severe or life-threatening. Call your healthcare provider or get emergency help right away if you get any of the following: fever (100.4°F/38°C or higher); chills/shivering; difficulty breathing; fast or irregular heartbeat; low blood pressure; fatigue; severe nausea, vomiting, or diarrhea; severe headache; or new skin rash. Tell all your healthcare providers that you were treated with TECELRA.
After getting TECELRA, you will be monitored daily at the healthcare facility for at least 7 days after the infusion. You should plan to stay close to a healthcare facility for at least 2 weeks. Do not drive, operate heavy machinery, or do other activities that could be dangerous for at least 2 weeks after you get TECELRA. Your healthcare provider will do blood tests to follow your progress. It is important that you have your blood tested. If you miss a scheduled appointment for your collection of blood, call your healthcare provider as soon as possible to reschedule.
Before you receive TECELRA, tell your healthcare provider about all the medicines and supplements you take and your medical conditions, including: seizure, stroke, confusion, or memory loss; heart, liver, or kidney problems; low blood pressure; lung or breathing problems; recent or active infection; past infections that can be reactivated following treatment with TECELRA; low blood counts; pregnancy, you think you may be pregnant, or plan to become pregnant; breastfeeding; or taking a blood thinner.
The most common side effects of TECELRA include nausea, fatigue, musculoskeletal pain, infection, fever (100.4°F/38°C or higher), constipation, vomiting, headache, diarrhea, cough, fast heart rate, swelling, shortness of breath, rash, increased aspartate aminotransferase, increased alanine aminotransferase, decreased lymphocyte count, decreased white blood cell count, decreased neutrophil count, decreased red blood cell count, and decreased platelet count.
You are encouraged to report side effects to the FDA at (800) FDA‑1088 or www.fda.gov/medwatch or to US WorldMeds at 1-855-246-9232.
What is TECELRA?
TECELRA® is a medicine, called a genetically modified autologous T cell immunotherapy, that is used to treat synovial sarcoma. It is used when other kinds of treatment do not work. TECELRA is different from other cancer medicines because it is made from your own white blood cells that are made to recognize and attack your cancer cells. Your healthcare provider will perform tests to see if TECELRA is right for you.
Please see Medication Guide, including Important Warning.